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Abstract
PURPOSE: The purpose of this project was to focus on caregiver education with an emphasis on
caregiver concerns regarding the LVAD; additionally, evaluating the efficacy of an educational
video acknowledging those device-related concerns identified by caregivers. The goal of this
project is to improve caregiver knowledge and decrease the rate of device related concerns
among the primary caregivers.
METHODS: This project is a single center cross-sectional, pre-post-test implementation design
to determine the efficacy of device related concerns education on primary caregivers’
knowledge and concerns. A 16-point device related concerns scale was designed to appraise
primary caregiver concerns. The scale used a 0-4 Likert scale ranking, 0- not concerned and 4very concerned. An educational video was developed and implemented to address the
concerns in the device related concerns scale. A post device related concerns scale used to
evaluate the efficacy of the educational video. Data was collection took place between
November 2020 and February 2021.
RESULTS: Thirty primary caregivers of VAD patients agreed to participate in this study. Twentyeight of those participants started with only twenty-one completing the online survey. There
was a significant decrease in caregivers concerns following implementation of the educational
video.
CONCLUSION: The findings from this cross-sectional pre- post- test study supports the
implementation of educational video in caregiver discharge teaching. As a result of this
intervention, caregivers reported a lower post concerns scale score, this coincides with a better
understanding and comfort with the LVAD
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Device Related Concerns pertaining to Primary Caregivers of LVAD Patients
Background and Significance
The number of Americans diagnosed with heart failure (HF) continues to rise annually,
as expected so does the demand for heart transplants. Each year the United Network for Organ
Sharing (UNOS) transplant list grows, leading providers and patients to consider alternative
treatment methods because of the scarcity of organ availability. Advancements in medical
technology and the introduction of Left Ventricular Assist Devices (LVAD) made it feasible for
individuals with HF to live longer, more meaningful lives while waiting on heart transplantation.
LVADs are mechanical circulatory support devices that help pump blood through the body in
the setting of heart failure. The projected number of LVAD implants rises annually, with
approximately 150,000 to 250,000 individuals eligible for implant each year (Magid et al., 2016).
Although caregivers are provided a tremendous amount of education from LVAD
coordinators, cardiac surgeons, and bedside nurses, they still leave the hospital with lingering
concern and doubt. It is not enough to educate these individuals pre-operatively and
throughout the course of their loved one’s hospitalization; it is imperative they are provided
continuous education post-discharge. To date, the education provided is insufficient in
preventing device related concerns identified by primary caregivers. Additionally, while VAD
technology may have progressed over time. The current educational content available to
patients and caregivers is based on outdated statistics and information created for a target
population with higher health literacy levels than a majority of LVAD caregivers (Iacovetto,
2014). The Center for Health Care Strategies states that nearly 36% of American adults have low
literacy levels, reading at a fifth-grade level; currently the majority of health care related
8

educational materials are written at a tenth-grade level (CHCS, 2013). Teaching and education
are often limited by the time and resources provided by LVAD centers. Furthermore, there is
little research focused on the device related concerns specific to the caregiver’s perspective.
For continual improvement in LVAD survival rates and quality of life (QOL) the current
educational and knowledge gaps need to be minimized or eliminated; this starts with placing
more focus on educational needs and device related concerns identified by caregivers.
Context of the Problem
Heart failure is a chronic disease process categorized as the reduction in the hearts
ability to pump blood to meet the needs of the body (Savarese & Lund, 2017). Nearly 5.7
million Americans are affected (CDC, 2019), or 26 million people worldwide (Savarese & Lund,
2017). Current data predicts a 46% increase in diagnoses rates, with an overwhelming 8 million
Americans diagnosed with HF by 2030 (Savarese & Lund, 2017). Approximately 915,000 new
diagnoses of HF occur annually in the U.S (Savarese & Lund, 2017.) Presently, individuals
diagnosed with HF are managed medically, as their disease progresses the treatment
alternative include cardiac transplant or Mechanical Circulatory Support (MCS) such as LVADs.
In 2000, United Network for Organ Sharing (UNOS, 2015) documented 2,199 heart transplants;
sixteen years later in 2016 there were 3,191 documented heart transplants. Due to the
advancement in medical therapies, patients have survived longer, becoming increasingly more
ill, and causing a spike in donor heart demand. Eisen, Hunt, & Yeon (2016) report that close to
5,000 cardiac transplants occur globally yearly. However, close to 50,000 individuals are waiting
on the transplant list. Due to increased demand in the absence of adequate availability of
organs, we’ve seen a rise in mortality of patients on the UNOS transplant list.
9

Scope and Consequences of the Problem
Over the last decade, there have been significant technological advancements in both
the medical and bioengineering fields, allowing medical professionals to provide improved
treatment, thus increasing longevity. Due to the excess of patients experiencing physical
decline while waiting on the transplant list, physicians worldwide have turned to MCS devices,
such as the LVAD, because the availability of these devices are essentially limitless (Bowen,
Graetz, Emmert, & Avidan, 2020).
The LVAD is a viable option for individuals diagnosed with end-stage heart failure.
Currently there are three indications in which an LVAD would be implanted: bridge-totransplant (BTT), destination therapy (DT), and Bridge-to-recovery (BTR). The 2017 INTERMACS
report Kirklin et al., 2017 revealed that, 22,866 patients received an FDA approved MCS device
between June 23, 2006 and December 31, 2016 with implantation rates close to 2,500 per year
(pg. 1080); of those patients who received a BTT LVAD implant, 30% went on to receive a
cardiac transplant.
In order to determine candidacy for an LVAD, specific workup must be done. The
process from initial evaluation to implant is extensive and focuses primarily on the patient.
However, road to implantation can be overwhelming and emotionally draining for both the
patient and their primary caregivers. Research indicates that 39.8 million individuals provide
upaid care to another adult in the United states annually (Birriel, Alonso, Kitko, & Hupcey,
2019). A pre-requisite for all LVAD programs nationally requires the commitment from a
primary caregiver; although the requirements from each institution vary (Magid et al., 2016).
10

Caregivers must be available for everyday management of the patient with a LVAD device
including but not limited to driveline dressing changes, battery changes, medication
management, arrangement of follow up appointments/ensuring transportation, and
responding to/ troubleshooting device alarms (Magid et al., 2016). The healthcare organization
for this project requires round the clock care for a minimum of 3 months, however, depending
on post-operative complications and patient quality of life, can continue throughout their
lifetime.
Technology has improved tremendously resulting in positive patient experience and
improved quality of life, better patient outcomes, and an 80% 1-year survival rate in the U.S.
(Birriel, Alonso, Kitko, & Hupcey, 2019). Patient caregiver engagement plays a large role in the
positive trend in patient outcomes and survival rate. Patients with caregivers who are engaged
in their care, remain informed, and take part in education and care discussions have reduced
mortality risk (Bruce et al., 2016). The role of primary caregiver can be burdensome; causing
added levels of stress (Kirkpatrick et al., 2015). To date most studies focused on caregivers of
LVAD patients are concentrated around caregiver role strain and quality of life post-discharge.
This project is important to the institution/setting for this study because of its growing
population of LVAD patients and the continual rise in LVAD implants. Improving caregiver
knowledge and decreasing the rate of device related caregiver concerns has the potential to
decrease the risk of poor patient outcomes, re-admission rates, and inappropriate calls to LVAD
coordinators. As well, improving caregiver knowledge also has the potential to increase survival
rates. Improvements in the matters discussed above could ultimately reduce the overall
financial burden on the Institution’s program. This research will allow for identification of areas
11

for improvement in device education while providing insight into creating interventions to close
these knowledge gaps.
Purpose of the Project
The purpose of this project is to evaluate efficacy of a device related concerns
educational video on reducing caregiver concern. The goal to improve caregiver knowledge and
decrease the rate of device related concerns among primary caregivers. The project has 4
objectives.
Study Objectives
1)Identify device-related concerns among primary caregivers, 2) enhance caregiver
education with video tailored to device related concerns, 3) determine the effects of the
educational video on caregiver concerns, 4) determine correlation between caregiver burden
and level of device related concern.
Theoretical Framework/Process Improvement Model
The framework for this project followed that of the uncertainty of illness theory (UIT).
This model focuses on the individuals’ inability to identify the meaning of their loved one’s
illness. Neville (2003), states that uncertainty can affect an individual’s psychosocial ability to
adapt as well as the outcome of their health. The UIT model focuses on three categories:
antecedents, appraisal, and coping with uncertainty (Mishel & Clayton, 2008). Lack of
information or vagueness in regard to a stressful situation can generate a negative health
trajectory. This theory focuses on individuals who have been diagnosed with or who provide
care for those diagnosed with chronic illnesses. Health care providers can facilitate a reduction
in caregiver’s uncertainty and improve their confidence in providing care.
12

Caregivers of individuals with LVADs are often anxious and concerned by their loved
one’s heart failure diagnosis. After LVAD implantation they are overwhelmed with information
necessary to care for an LVAD. Additionally, they must understand the intricacies and
management of the device. It is the job of the healthcare provider to provide well thought out,
concise information tailored to the caregiver to help alleviate uncertainty. The goal of the prepost questionnaire design with LVAD Concerns educational video is to identify device-related
concerns, provide educational video and then take the post-questionnaire. The hope is that the
video will alleviate the caregiver’s uncertainty related to the LVAD and help them adapt to their
new role and the stressors and uncertainty that come with it.
Review of Literature
Search Methods
A literature review was conducted by a thorough and extensive search of University of
Kentucky’s online library using the following key terms “LVAD”, “left ventricular assist device”,
“education”, “video”, “educational video”, “LVAD education” and “caregiver”. This was a multidatabase search including PUBMED, CINAHL, and EBSCO HOST.
Inclusion criteria for this search was limited to full text, peer reviewed academic
journals, published in the last 20 years, human subjects, adults 18 years of age. Exclusion
criteria includes non-English, non-academic, non-peer-reviewed journal articles, written before
2003. A total of 74 articles were found during the initial literature search. After careful review
and elimination based on exclusion criteria, only 5 articles remained. The research team
consisted of one member enrolled in the University of Kentucky Doctoral of Nursing Program
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(DNP), with seven years of CVICU experience in the Cardiovascular intensive care unit (CVICU),
working with LVAD patients and caregivers.
Synthesis of Evidence
The five studies in this sample includes one cross-sectional study, one quality
improvement project, one randomized and prospective study-controlled trial, and 2 controlled
clinical studies. The individuals included in all five studies underwent an intervention that
included an educational video (Costelle, D., Harman, J., & Moser, D. 2019; Du, W., Mood, D.,
Gadgeel, S., & Simon, M.S., 2008; Gause, A., &Rehman, Z., 2017; Gonzalez-Arriagada, W.A. de
Andrade, M.A.C., L.M.A., Bezerra, J.R.S., Santos-Silva, A.R., & Lopes, M.A., 2013; Park, J.S., Kim,
M.S., Kim, S.I., Shin, C.H., Lee, H.J.,…& Moon, S., 2016).
All five studies used a pre- post-test design to evaluate the efficacy of the intervention.
While research shows correlation between educational videos and improvement in post-test
scores, only three studies found implementation of the educational video statistically significant
in improving outcomes (Costelle, D., Harman, J., & Moser, D. 2019; Park, J. S., Kim, M. S., Kim,
H., Kim, S. I., Shin, C. H., Lee, H. J., ... & Moon, S., 2016; Du, W., Mood, D., Gadgeel, S., & Simon,
M.S., 2008). Costelle, Harman, & Moser (2019) found their LVAD concerns educational video
produced a statistically significant reduction in concerns among LVAD recipient’s postimplantation (p-value of 0.002). Their pre- post- test was a 15-point scale scored using a Likert
scale. Results showed statistical significance in seven of the 15 concerns (Costelle, D., Harman,
J., & Moser, D. 2019). Park et al., (2016) established that the educational video produced
statistically significant results. Their study focused on the impact an educational video on bowel
preparation pre-colonoscopy effected the OTTAWA score post colonoscopy. Results showed
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those who were enrolled in the educational video group exhibited better bowel preparation,
with a P-value of <0.001 and an OTTAWA score of < 6, compared to the non-video group (Park
et al., 2016). A study performed by Du, W., Mood, D., Gadgeel, S., & Simon, M.S. (2008) focused
on the efficacy of an educational video on an individual’s attitudes concerning enrollment in
clinical trials. Results from their study revealed a statistically relevant impact on patients’
attitude towards participation in a clinical trial (p= 0.019); however, there was no statistically
significant increase in clinical trial enrollment (2013; Du, W., Mood, D., Gadgeel, S., & Simon,
M.S., 2008).
Furthermore, two studies found no statistically significant change with the
implementation of an educational video intervention. Gause, A., &Rehman, Z., 2017 performed
a quality improvement pilot study that implemented a video based LVAD education program to
evaluate the Knowledge of the LVAD population in Certified Registered Nurse Anesthetists
(CRNA’s) and Student Registered Nurse Anesthetists (SRNA’s). Gonzalez et al. (2013) performed
a longitudinal control clinic trial aimed at assessing the effects of an educational video on
improving knowledge and understanding of radiotherapy treatment complications. Data
disclosed no statistical significance in post-test results between the control group and video
group (Gonzalez et al., 2013).
Discussion of Literature Review
Limitations
The discriminating power of a study can be significantly decreased by small sample
sizes; four of the five studies (Gonzalez-Arriagada, W.A. de Andrade, M.A.C., L.M.A., Bezerra,
J.R.S., Santos-Silva, A.R., & Lopes, M.A., 2013; Du, W., Mood, D., Gadgeel, S., & Simon, M.S.,
15

2008; Gause, A., &Rehman, Z., 2017; Costelle, D., Harman, J., & Moser, D., 2019) were limited
by small sample size. The sample in Gonzalez et al., (2013) was limited due to the severity of the
disease and deterioration of patients; several patients were either too ill or deceased before
completing their post-test. The small sample size in Du, Mood, Gadgeel, & Simon (2008) limited
the studies ability to identify statistical power to show difference in clinical trial enrollment rate
pre- and post-intervention. Studies performed by Costelle, Thompson, & Moser (2019) and
Gause & Rehman (2017) were also limited to a small sample size due to their single-center
study design; this also decreased the ability for generalization among other LVAD centers.
Identifying Gaps in Practice
It should also be noted that none of the studies included in the literature review for
focused on the LVAD caregiver (Costelle, D., Harman, J., & Moser, D. 2019; Du, W., Mood, D.,
Gadgeel, S., & Simon, M.S., 2008; Gause, A., &Rehman, Z., 2017; Gonzalez-Arriagada, W.A. de
Andrade, M.A.C., L.M.A., Bezerra, J.R.S., Santos-Silva, A.R., & Lopes, M.A., 2013; Park, J.S., Kim,
M.S., Kim, S.I., Shin, C.H., Lee, H.J.,…& Moon, S., 2016). Presently there are more than a few
studies that incorporated educational videos as their intervention; a majority of those studies
focus on the patient population, with very few focused on the caregiver perspective. An LVAD
concerns educational video has been used as an intervention in a recent single center crosssectional study, the population of focus were the LVAD recipients themselves. To date there are
no published studies using an LVAD concerns educational video with principal focus being the
primary caregivers of LVAD recipients. Additionally, there are very few studies concentrating on
device related concerns and even fewer studies that place emphasis on the caregiver role. The
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lack of cohesion in research has created a gap in knowledge causing difficulty in identifying
methods to bridge that knowledge gap.
Project Agency Description
Site Description
This is a single center study performed at a tertiary care academic medical center in
Lexington, Kentucky. The University of Kentucky is Level 1 Magnet certified, Academic trauma
center. UK Gill Heart & Vascular institute is a certified Left Ventricular Assist Device program
holding The Joint Commission Gold seal of approval since 2009 (UK Healthcare, n.d.) University
of Kentucky is an 865-bed facility in central Kentucky that admits and treats patients
throughout Kentucky and its surrounding states.
The Cardiothoracic program at UK hospital performed their first LVAD implant in 1995
(Perry, A., 2014); they currently perform roughly 20-25 LVAD implants annually. The LVAD
program employs two cardiothoracic surgeons, four LVAD coordinators, three heart failure
physicians and a multitude of nurse practitioners that provide specialized care for these
patients.
Congruence of DNP project to organizations, missions, goals, and strategic plan
University of Kentucky Health Care’s (UKHC) mission, vision, and values have developed
a healthcare enterprise that’s been ranked as the number one Hospital in the state of Kentucky.
The mission statement that guides their care reads “providing leading-edge care while
advancing professional nursing and practice” (UK healthcare, n.d). Senior leadership at UKHC
are focused on providing exceptional care to their patient population by identifying and
incorporating cutting edge and evidence-based practice to their healthcare strategy.
17

UK Healthcare implemented their first five-year strategic plan in 2004; they’ve
continued to use these plans as a road map to development and improvement of the
enterprise, creating a firm foundation to build for the future (Capilouto, E., n.d.). Growth in
complex care is identified as a key pillar in the 2015-2020 strategic plan, providing advanced
sub-specialty care to every Kentuckian, every time, ensuring that every aspect of care needed
can be obtained in the state of Kentucky. The Gill heart institute identified their strategic
aspiration was to become a leader in the management of organ failure through focused patient
outcomes (Capilouto, E., n.d.).
Description of Stakeholders
The stakeholders include UK Director of HF, Heart failure Operations Director, LVAD
coordinators, and caregivers of LVAD patients. The success of this project was dependent on
the willingness and support from many different parties. Before beginning, Director of Heart
Failure and the LVAD team pledged their help and resources for this project. Active
participation by LVAD coordinator (Carissa Smith) was instrumental in the creation and
development of the device related concerns survey and educational video. LVAD coordinator,
Rachel Unger, was key in identifying primary caregivers that fit criteria for participation in this
study. The MCS/LVAD secretary assisted with initial contact and obtaining interest in study
participation. Buy in from the primary population was critical; without their willingness and
cooperation this study would not have been possible. Additionally, it is this group who will be
most affected by data obtained from this study.
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Site-Specific Facilitators and Barriers
Barriers to this study include unwillingness of the primary caregiver to participate in this
study. All LVAD patients have an identified primary caregiver when they begin their initial
evaluation prior to implant. Overtime, some caregivers become less involved in the care of their
loved one. This would reduce their desire to take part in this study. Another barrier to
implementation involved the caregiver completing the survey once receiving it. Once agreeing
to participate, the caregiver must take the time to go online and complete it. Potential difficulty
navigating the online survey and ability to use technology could hinder survey completion.
Alternatively, an important facilitator to this study involved the Principal Investigator
(PI) being a current CVICU nurse at UK healthcare. This allowed her the opportunity to build a
rapport with the LVAD coordinators as well as the patient population and their families.
Project Sample and Recruitment
The target population for this study includes the primary caregivers (Mom, Dad, wife,
husband, child, etc.) of LVAD patients who receive follow-up care through the UK LVAD
program. Inclusion criteria for this project included: 1) primary caregiver of LVAD patient, 2)
only primary caregivers of LVAD patients receiving follow up care by UK LVAD program, 3) able
to speak and write English, 4) able to fill out a questionnaire. Exclusion criteria: 1) not the
primary caregiver of LVAD patient, 2) caregiver less than 18 years of age, 3) primary caregivers
of LVAD patients receiving follow up care outside of UK LVAD program 4) unable to speak or
write English, 5) unable to complete questionnaire.
All primary caregivers of individuals receiving follow-up care at UK were reviewed for
suitability for this study. Provided with the inclusion/exclusion criteria the LVAD coordinator
19

compiled a list of potential candidates, that list was passed along to the Mechanical Circulatory
Support (MCS) secretary who called those individuals for potential participation. The first 30
participants to provide consent were included in the study. Thirty-three caregivers were
contacted for participation; thirty primary caregivers (n=30) consented to participate in the
study.
Project Design and Methods
The aim of this study was to identify specific device related concerns that afflict the
primary caregivers of patients implanted with LVAD devices and observe the effect an
educational video has on alleviating the caregiver’s concerns. This project is a single-center
study that took place at the University of Kentucky; it follows a cross-sectional, pre- post-test
design.
Description of Intervention
LVAD Concerns Scale
The LVAD concerns scale is 16-point scale developed to identify device related concerns.
This scale was adopted for use based on the LVAD concerns scale used in a cross-sectional study
focused on device related concerns in individuals who underwent recent LVAD implantation at
University of Kentucky Chandler Medical Center (Costelle, 2019). That scale was altered and
tailored to focus on device related concerns pertaining to the primary caregivers of LVAD
patients. The survey used a Likert scale rating of 0-4: 0- not concerned at all, 1- a little
concerned, 2- somewhat concerned, 3- quite a bit concerned, 4- very concerned. The concerns
listed were extrapolated from the most commonly asked questions experienced by the LVAD
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caregivers at the University of Kentucky. Before using this scale, it underwent a face validity test
involving review and approval by the LVAD coordinators.
LVAD Concerns Educational Video
The device related concerns educational video was developed and guided by the device
related concerns scale. The script for the video was created by an LVAD coordinator at the
University of Kentucky. The completed video was reviewed by LVAD coordinator and CVICU
nurse at the University of Kentucky to ensure all concerns were included with information that
is clear and concise. In addition, the information provided was delivered at a health literacy
level approved by the University of Kentucky.
Procedures
IRB Determination
Approval for the study was obtained from the University of Kentucky Office of Research
and Integrity (IRB) on October 6th, 2020. A waiver of documentation of informed consent was
approved for this study. The application underwent intense scrutiny by the IRB board and ORI
privacy specialist; it was determined that Health Insurance Portability and Accountability Act
(HIPAA) applied. The UKHC IRB representative notified the PI of the request for Form K, HIPAA
Waiver of Authorization. The electronic pre-and post-device related screening survey were
sent to participants via email through UK REDCaps system, a secure web-based application for
building and maintaining databases.
Data Collection
The primary investigator (P)I provided a list of the inclusion and exclusion criteria to the
UK healthcare LVAD coordinator. The LVAD coordinator then compiled a list of all potential
21

participants then referred it to the MCS/LVAD secretary. These individuals were then contacted
by the MCS/LVAD secretary to identify potential interest in study participation. If aggregable to
further discussion, the secretary forwarded their contact information to the PI. Individuals were
contacted by the PI and provided an in-depth explanation about the study including the
purpose and what participation entailed. Time was provided for each individual to ask any
questions or identify any concerns. Potential participants were notified that they could, at any
time, remove themselves from the study. Once the individual agreed to participate, the PI
engaged in a discussion identifying the next steps. The participants provided their email address
to the PI who then sent them a survey link that was developed using REDcaps. The survey link
provided a seamless transition from one aspect of the study to the next. The transition through
the link was as followed: cover letter, sociodemographic survey, device related concerns scale
(pre), educational video, device related concerns scale (post). All data was collected using
REDcaps provided de-identified data to the PI. This data was saved on the PI’s personal
password protected laptop and encrypted flash drive.
The study measures used are exhibited in (table 1). The dependent variable for this
study is the primary caregivers with device related concerns. These are concerns identified, in
the past, by primary caregiver to LVAD coordinators or bedside nurses. Furthermore, the
independent variable and subsequently the intervention of this study is the device related
concerns video. The instruments used to complete this study included: Sociodemographic
survey (Appendix A); Device Related Concerns Scale (Appendix B).
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Data Analysis
Research procedures included collection and analysis of descriptive statistics comprised
of means and standard deviations or frequency distributions, as appropriate. These tests were
used to summarize the sociodemographic and clinical characteristics of the sample of
caregivers. Spearman’s correlation coefficient was used to examine the association between
burden of disease and level of concern with LVAD operations. Comparisons of pre- and posteducational intervention level of concern with LVAD operations were conducted using a paired
t-test. All data analysis was conducted using SPSS, version 25, with an alpha level of .05
throughout.
Results
Sample Characteristics
A total of 33 primary caregivers were contacted by the PI for potential participation, 30
caregivers agreed to participate, 28 started the survey with only 21 completing it. Of the twenty
eight caregivers completed the sociodemographic study, the average age was 55.1 years (SD=
15.4; see table 2). The majority of the participants were female (82%) and partnered (75%).
Most of the participants were white/Caucasian (86%), with the rest being black/African
American (14%). Almost one-third identified as having some college/associates degrees (61%).
Overall, 92.9% (n=26) identified they were the primary caregiver to only one individual, 13%
(n=1) caring for two individuals and 13% (n=1) caring for three or more individuals. Over half
the participants (57.1%) indicated they were currently employed. When identifying the
presence of additional conditions, other than HF and LVAD, their loved one was diagnosed with,
nearly one-third (32.1%) identified one extra condition; furthermore, one-third (32.1%)
23

identified an additional four conditions. Overall, data showed that loved ones suffered from:
congestive Heart failure (89%), chronic pulmonary disease (37.5%), Myocardial infarction
(28.6%), Diabetes Mellitus (28.6%), stroke (21.4%), kidney disease (21.4%), peripheral vascular
disease (14.3%), connective tissue disease (10.7%), peptic ulcer disease (10.7%), dementia
(7.1%), and cancer 7.1%).
Outcome
Implementation of the educational video resulted in a significant reduction in concern
with a p-value 0.025 (table 3). A further dive into the data revealed that five of the 16 device
related concerns showed significant reduction in concerns. Measured on a scale of 1-5, with
higher scores representing more concern, there was a significant decrease in fear of the LVAD
stopping abruptly (M= 2.6 pre vs. M= 2.0 post, p= .029. Additionally, there was a significant
decrease in concern for the LVAD alarming (M= 2.0 pre vs. 1.6 post, p= .012). The intervention
also had an effect in reducing concerns regarding both drive line infection (M= 2.38 pre vs M=
2.00 post, p= .042) and concern for the future (M= 2.67 pre vs. M= 2.05 post, p= .009). Lastly,
there was a significant reduction in concerns regarding secondary risk factors (M= 2.57 pre vs.
M= 2.14 post, p= .025). There was no significant reduction in the remaining device related
concerns: batteries dying (p=.08), loved one’s condition worsening (p=.095), traveling with an
LVAD (p=.171), intercourse (p=.171), driveline trauma (p=.055), anxiety (p=.309), loss of
independence (p=.358), calling the coordinator (p=.056), calling EMS (p=.666), rehospitalization (p=.590), and lastly, concern that something will happen when the caregiver is
gone (p=.162). See (table 4).
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Additionally, the spearman’s coefficient test was used to identify the relationship
between caregiver burden and level of concern. There was a significant association between
level of sickness (caregiver burden) and level of concern rho= 0.42 (p=.016). Refer to table 5.
For breakdown of correlations.
Discussion
Previous studies have focused on device related concerns from the perspective of the
LVAD patient. The purpose of this cross-sectional pre- post- test study was to identify caregiver
specific device related concerns and determine the efficacy of a tailored educational video.
Overall, data showed a statistically significant reduction in caregiver concerns following
implementation of the educational video. Each participant filled out a device related concerns
scale before watching the educational video. This scale was comprised of 16 concerns; of those
16 concerns participants experienced a significant reduction in five.
A majority of the participants acknowledged concerns regarding the future of their
loved one now that they have an LVAD, the other regarding secondary risk factors of LVAD
implantation. Caregivers of individuals diagnosed with chronic diseases, such as HF, are often
faced with the uncertainty of their loved one’s future. Implantation of the LVAD provides them
with hope for longer life expectancy allowing them the ability to move on with their lives.
However, living with an LVAD can generate its own concerns, particularly those involving the
future and occurrence of secondary risk factors such as gastrointestinal bleeding and stroke.
This development implies that throughout pre and post LVAD education, more emphasis could
be applied in detailing what to expect in the future while highlighting the potential for

25

secondary risk factors. From the data it can be determined that the change in level of concerns
demonstrates the caregivers responded well to the intervention.
Despite extensive education and training throughout the implant process caregivers are
unaware of fears that may overwhelm them. It’s vital to understand that the LVAD is necessary
in keeping the loved one alive; and fear of pump failure is not just specific to the LVAD patient.
The caregivers of these individuals live with the constant fear of pump failure or malfunction.
Of Note in this study participants expressed concern pertaining to the actual LVAD, including
the device stopping without warning and the device alarming and not knowing what to do.
Assessment of the post concerns scale revealed the implementation of the educational video
was valuable in reducing these concerns.
The next steps for this study would include expanding enrollment by including other
LVAD centers across the nation. A larger multi-center study would provide better insight on
generalizability of this device related concerns scale and the educational video. Additionally, it
is recommended to include in-person meetings when discussing and disseminating the survey
to participants. This alteration could help mitigate any technological issues while also providing
extra support to participants experiencing difficulty. In future studies, it may be beneficial to
limit enrollment to caregivers of LVAD patients implanted within the last 6 months to a year as
this population likely may be more affected by device related concerns. Additionally, future
research could focus on identifying the of this educational video when comparing level of
concern among caregivers of loved ones implanted with an LVAD less than a year ago versus
long-term caregivers caring for individuals implanted greater than a year ago. It is likely that all
caregivers suffer from concerns, however the concerns experienced by long term caregivers are
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to differ from those individuals caring for individuals implanted less than a year ago. Addressing
the unique concerns for each group of caregivers could provide better insight into development
of more precise education.
The study identified two driveline associated concerns among caregivers: drive line
infection and driveline trauma. The driveline is an important aspect of the LVAD, providing
power necessary for the device to function. The driveline is prone to trauma and infection; this
can lead to hospitalization, antibiotic therapy, and possible operation. The pre concerns scale
recognized presence of concern for both driveline trauma and infection. Post concerns scale
data recognizes the educational video was successful in reduction of concerns regarding
driveline infection but not driveline trauma. This highlights the needs for re-education and
further instruction regarding drive line management from the caregiver perspective.
Despite increased access to LVAD educational resources and materials, device related
concerns still linger. Tailored education is important for individuals caring for LVAD patients
requiring more assistance. Study data illustrates a positive correlation between caregiver
burden, how sick caregivers perceive their loved ones are, and the level of concern among the
caregivers. Individuals living with higher levels of caregiver burden identified having higher
levels of device related concern. The evidence suggests that providing tailored education
focused on device related concerns for caregivers should be optimized prior to hospital
discharge.
Implications
Several implications can be drawn from the evidence derived from this study. The first
being there is a need for further research into the efficacy of educational videos on reducing
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device related concerns, particularly those that afflict the primary caregiver. Future research
could identify efficacy of the video among new LVAD caregivers (<1 year) compared to longterm caregivers (>1 year). Additionally, research could provide more detailed insight, while
identifying educational interventions to help improve current gaps. Another aim could focus on
evaluating the number of phone calls to the emergency number experienced by LVAD
coordinators.
Furthermore, the pre- post- data collected in this study deduced that a tailored
educational video was successful in the reduction in concerns among caregivers. Additionally,
these findings support the need for additional education both pre and post hospital discharge.
Development and implementation of standardized caregiver-based education sessions at 6
months and 1-year post- implantation.
Limitations
There are several limitations to this study. The first and most notable limitation was
small sample size. Having a larger sample size would have provided more data therefore
providing more conclusive results. Additionally, this was a single center study with a relatively
small LVAD population. The concerns identified in this study were those only recognized by the
LVAD coordinators from UKHC. The coordinators work with patients and caregivers from KY and
the surrounding regions; while these concerns may be significant to this patient population it
may not match those from other regions. Additionally, due to the Covid-19 pandemic all
elective procedures were cancelled causing a reduction in the number of LVAD implants in
2020. Furthermore, the global pandemic limited visitation at UKHC; therefore, instead of
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performing this study in person the participants were sent a survey link over email. Therefore,
potentially limiting the number of survey results received.
Conclusion
The study showed the educational video had a significant impact. Data revealed that
there was a significant reduction in device related concerns when comparing pre-score to postscores. Caregivers reported a lower post concern score which coincides with a better
understanding and comfort with the device. These scores along with the reduction in the device
related concerns indicated the need for an educational video to be included in the caregiver
discharge teaching at the University of Kentucky. It also identifies the need for further research
focused on gaps in caregiver education and device related concerns.
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Appendices
Appendix A: SOCIODEMOGRAPHIC CHARACTERISTICS
1. Sex: 0.______ Female
1.________Male
2.________Other
2. Age: ___________ Years Old
3. Marital Status:
1.__________ Single
2.__________ Married
3.__________ Divorced/Separated
4.__________ Widowed
5.__________ Co-Habitate
4. Ethnicity: select all that apply
1.__________ Black or African American (Not Hispanic or
Latino)
2.__________ White or Caucasian (Not Hispanic or Latino)
3.__________ Hispanic or Latino
4.__________ American Indian or Alaskan Native
5.__________ Native Hawaiian or other Pacific Islander
6.__________ 0ther (Please specify ____________________)
5. What is the Highest Level of Education you have Completed?
1.__________ Less than high school graduate
2.__________ High school graduate
3.__________ Some post high school
4.__________ Some college
5.__________ Associate Degree
6.__________ Bachelor’s Degree
7.__________ Master’s Degree
8.__________ Professional Degree
9.__________ Doctoral Degree

6. How many individuals are you the Primary Caregiver for?
1.___________ 1
2.___________ 2
3.___________ 3
4.___________ 4
5.___________ 5
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6.___________ 6 or more
7. Are you currently employed?
0.___________ No
1.___________ Yes
8. How sick/complicated do you think your loved one (with an LVAD) is?
1.___________Only problem they have is LVAD with HF
2.___________One Conditions in addition to HF and LVAD
3.___________Two Conditions in addition to HF and LVAD
4.___________Three Conditions in addition to HF and LVAD
5.___________Four conditions in addition to HF and LVAD
6.___________Five or more conditions in addition to HF and
LVAD
9. What other conditions does your loved one have? Select all that apply
Does the participant have?
1. Myocardial Infarction (Heart attack)
2. Congestive Heart Failure
3. Peripheral Vascular Disease
4. Cerebrovascular Disease (Stroke)
5. Dementia
6. Chronic Pulmonary Disease (COPD, Asthma)
7. Connective Tissue Disease (Lupus, rheumatoid arthritis,
scleroderma)
8. Stomach or Peptic Ulcer Disease
9. Hemiplegia (paralysis)
10. Diabetes
11. Moderate to severe Kidney disease/failure
12. Cirrhosis or liver disease
13. Cancer
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☐ No
☐ No
☐ No
☐ No
☐ No
☐ No

☐ Yes
☐ Yes
☐ Yes
☐ Yes
☐ Yes
☐ Yes

☐ No
☐ No
☐ No
☐ No
☐ No
☐ No
☐ No

☐ Yes
☐ Yes
☐ Yes
☐ Yes
☐ Yes
☐ Yes
☐ Yes

Appendix B: LVAD Concern Scale
LVAD Concerns Scale

I am worried about:

0 Not
1 A little 2 Somewhat 3 Quite a bit 4 Very
concerned at
concerned concerned concerned concerned
all

LVAD battery/s dying
LVAD stops working suddenly
and without warning
LVAD alarming and not
knowing what to do
Their heart condition getting
worse and the LVAD not being
enough to support their heart
Being able to travel (driving,
flying, etc.) with the LVAD
Having intercourse and their
LVAD alarming or stop working
Trauma to driveline site
Infection of Driveline site
My anxiety or nerves affecting
my relationship/making them
worry too much
The future now that they have
an LVAD
Patient losing their
independence with their
health because I do too much
for them
Concerns related to Secondary
risk factors (stroke, GI bleed)
related to LVAD placement
When to call the LVAD
coordinator
Concerns regarding calling 911
Concerns regarding rehospitalization
Something happening to them
while I’m gone
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Tables
Table 1: Study Variables
variable

Strategy for measurement (chart audit
or survey—specify which surveys you
will be using)
Device Related Concerns Scale

Level of
measurement

Timing of
measurement

Outcome Variable 1
Individual
PreDevice related
item scores
intervention
concerns pre-LVAD
and overall
educational video
score.
Outcome Variable 2
Device Related Concerns Scale
Individual
PostDevice related
item scores
intervention
concerns post-LVAD
and overall
educational video
score.
DEMOGRAPHIC VARIABLES – For Primary Caregivers of LVAD Patients
ALL MEASURED AT STUDY COMPLETION
Age
Age of participants in years
Continuous
At study
completion
Race/ethnicity

Marital Status
Sex
Level of Education

Number of
Individuals Primary
Caregiver for
Employment Status
Sick/complicated
illness of loved one

Additional Conditions

Ethnicity (African American/Black,
Caucasian/White, Hispanic/Latino,
American Indian/Alaskan native, Native
Hawaiian or other Pacific Islander,
Other)
Married, divorced/separated, single,
widowed, co-habitation
Sex (male, female, other)

Nominal

At study
completion

Nominal

Less than High school graduate, High
school graduate, Some post high
school, Some college, Associate degree,
Bachelor’s degree, Master’s degree,
Professional degree, Doctoral degree
1, 2, 3, 4, 5, 6 or more

Nominal

At study
completion
At study
completion
At study
completion

Nominal

At study
completion

Yes or No

Nominal

LVAD and HF, one condition in addition
to LVAD and HF, 2 conditions in
addition to LVAD and HF, 3 conditions
in addition to LVAD and HF, 4
conditions in addition to HF, 5 or more
conditions in addition to LVAD and HF
Select all that apply

Nominal

At study
completion
At study
completion
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Nominal

Nominal

At study
completion

Test Statistic

Paired t- test

Paired t- test

Mean and
standard
deviation
Frequency and
percentage

Frequency and
Percentage
Frequency and
Percentage

Frequency and
Percentage

Table 2: Sociodemographic Data (N = 28)
Characteristic
Age
Gender
Male
Female
Partnered status
Partnered
Not partnered
Race
White/Caucasian
Black/African American
Education
High school or less
College/Associates degree
Bachelors/master’s degree
Caregiver to # of individual
1 individual
2 individuals
3 or more individuals
Employment
Yes
No
How many conditions in addition to HF and LVAD
One Condition in addition
Two Conditions in addition
Three Conditions in addition
Four or more Conditions in addition
Other Conditions
MI
CHF
PVD
Stroke
Dementia
CPD
CTD
PUD
Paralysis
DM
KD
Liver disease
Cancer

Mean (SD) n (%)
55.1 (15.4)
5 (17.9%)
23 (82.1%)
21 (75.0%)
7 (25.0%)
24 (86%)
4 (14%)
5 (18%)
17 (61%)
6 (21%)
26 (92.9%)
1 (3.6%)
1 (3.6%)
16 (57.1%)
12 (42.9%)
9 (32.1%)
3 (10.7%)
7 (25%)
9 (32.1%)
8 (28.6%)
25 (89.3%)
4 (14.3%)
6 (21.4%)
2 (7.1%)
10 (35.7%)
3 (10.7%)
3 (10.7%)
0 (0%)
8 (28.6%)
6 (21.4%)
0 (0%)
2 (7.1%)
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Table 3: Comparison of Concerns Pre and Post video implementation
Paired Samples Test (Table 3)
Paired Differences
95% Confidence Interval of the
Difference
Mean
Std.
St.
Lower Upper
T
Df
Sig.
Deviation Error
(2Mean
tailed)
Pair 1
5.19048
9.80622 2.13989 .72674 9.65421 2.426 20
.025
concernPREfixconcernPOST
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Table 4: Comparison of Concerns Pre and Post Video Implementation by question

On a scale of 1 -5,
how concerned are
you about ……
LVAD battery dying
LVAD stops working
LVAD alarming
Condition worsening
Travel
Intercourse
Trauma
Infection
Future
Anxiety
Independence
Secondary Risk
factors
Call coordinator
EMS
Re-hospitalization
Gone

Pre-intervention
Mean (SD)

Post-intervention
Mean (SD)

p

2.0 (1.3)
2.6 (1.3)
2 (1.4)
3.05 (1.5)
2.0 (1.3)
1.52 (0.981)
2.33 (1.197)
2.38 (1.244)
2.67 (1.238)
2.05 (1.499)
2.14 (1.236)
2.57 (1.207)

1.6 (1.0)
2 (0.98)
1.6 (0.93)
2.62 (1.16)
1.76 (0.995)
1.48 (0.928)
2.05 (1.024)
2.00 (1.049)
2.05 (1.071)
1.91 (1.167)
1.95 (0.973)
2.14 (0.964)

.08
.029
.012
.095
.171
.715
.055
.042
.009
.309
.358
.025

1.62 (1.161)
1.33 (0.577)
2.29 (1.271)
3.19 (1.436)

1.38 (0.973)
1.43 (1.076)
2.14 (1.315)
2.81 (1.47)

.056
.666
.590
.162
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Table 5: Correlation of caregiver burden to concern
how_sick
Spearman’s rho

How_sick

concernPOST

concernPREfix

Correlation coefficients
Sig. (2-tailed)
N
Correlation Coefficient
Sig. (2-tailed)
N
Correlation Coefficient
Sig. (2-tailed)
N

*. Correlation is significant at the 0.05 level (2-tailed).
**. Correlation is significant at the level (2-tailed).
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concernPOST
1.000
.
28
.519*
.016
21
.247
.206
28

.519
.016
21
1.000
.
.21
.664**
.001
21

